Granulocyte transfusions in severe aplastic anemia: An eleven-year experience

Haematologica

Volumn 94, Issue 12, 2009, Pages 1661-1668

  Quillen, Karen ^a   Wong, Edward ^a   Scheinberg, Phillip ^b   Young, Neal S ^b   Walsh, Thomas J ^c   Wu, Colin O ^b   Leitman, Susan F ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Granulocyte; Severe aplastic anemia; Transfusions

Indexed keywords

ALEMTUZUMAB; AMPHOTERICIN; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYCLOSPORIN A; DEXAMETHASONE; GRANULOCYTE COLONY STIMULATING FACTOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENTAMIDINE; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THYMOCYTE ANTIBODY; VALACICLOVIR;

ACUTE LUNG INJURY; ADOLESCENT; ADULT; AGED; ALLOIMMUNIZATION; ANTIBIOTIC THERAPY; APLASTIC ANEMIA; ARTICLE; BACTERIAL INFECTION; CHEMOPROPHYLAXIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOMYCOSIS; DRUG DOSE REDUCTION; FEBRILE NEUTROPENIA; FEMALE; GRANULOCYTE TRANSFUSION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPES SIMPLEX; HLA SYSTEM; HOSPITAL DISCHARGE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; LEUKAPHERESIS; LUNG MYCOSIS; MALE; MYCOSIS; NEUTROPHIL CHEMOTAXIS; NEUTROPHIL COUNT; PNEUMOCYSTIS PNEUMONIA; PRESCHOOL CHILD; RELAPSE; RETROSPECTIVE STUDY; SCHOOL CHILD; SERUM SICKNESS; SEVERE APLASTIC ANEMIA; SINGLE DRUG DOSE; SURVIVAL; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; ANEMIA, APLASTIC; BACTERIAL INFECTIONS; BLOOD TRANSFUSION; CHILD; FEMALE; GRANULOCYTES; HUMANS; MALE; MIDDLE AGED; MYCOSES; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SURVIVAL RATE; YOUNG ADULT;

EID: 73149084432     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2009.010231     Document Type: Article

References (30)

1. Peters C, Minkov M, Matthes-Martin S, Potschger U, Witt V, Mann G, et al. Leucocyte transfusions from rhG-CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients. Br J Haematol 1999;106:689-96.
2. Price TH, Bowden RA, Boeckh M, Bux J, Nelson K, Liles WC, Dale DC. Phase I/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation. Blood 2000;95:3302-9.
3. Hubel K, Carter RA, Liles WC, Dale DC, Price TH, Bowden RA, et al. Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donors. Transfusion 2002;42:1414-21.
4. Safdar A, Hanna HA, Boktour M, Kontoyiannis DP, Hachem R, Lichtiger B, et al. Impact of high-dose granulocyte transfusions in patients with cancer with candidemia. Cancer 2004;101:2859-65.
5. Mousset S, Hermann S, Klein SA, Bialleck H, Duchscherer M, Bomke B, et al. Prophylactic and interventional granulocyte transfusions in patients with haematological malignancies and life-threatening infections during neutropenia. Ann Hematol 2005;84:734-41.
6. Grigull L, Pulver N, Goudeva L, Sykora KW, Linderkamp C, Beilken A, et al. G-CSF mobilized granulocyte transfusions in 32 paediatric patients with neutropenic sepsis. Support Care Cancer 2006;14:910-6.
7. Torres HA, Bodey GP, Rolston KVI, Kantarjian HM, Raad II, Kontoyiannis DP. Infections in patients with aplastic anemia. Cancer 2003;98:86-93.
8. Rosenfeld S, Follman D, Nunez O, Young NS. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA 2003;289:1130-5.
9. Walsh TJ, Pappas P, Winston DJ, Lazarus HM, Petersen F, Raffali J, et al. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. New Engl J Med 2002;346:225-34.
10. Scheinberg P, Nunez O, Wu C, Young NS. Treatment of severe aplastic anaemia with combined immunosuppression: anti-thymocyte globulin, ciclosporin and mycophenolate mofetil. Br J Haematol 2006;133:606-11.
11. Scheinberg P, Nunez O, Young NS. Retreatment with rabbit anti-thymocyte globulin and ciclosporin for patients with relapsed or refractory severe aplastic anaemia. Br J Haematol 2006;133:622-7.
12. Tisdale JF, Dunn DE, Geller N, Plante M, Nunez O, Dunbar CE, et al. High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial. Lancet 2000;356:1554-9.
13. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/ Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008;46:1813-21.
14. Weinberger M, Elattar I, Marshall D, Steinberg SM, Redner RL, Young NS, Pizzo PA. Patterns of infection in patients with aplastic anemia and the emergence of aspergillus as a major cause of death. Medicine 1992;71:24-43.
15. Price TH. Granulocyte transfusion: current status. Semin Hematol 2007;44:15-23.
16. Vamvakas EC, Pineda AA. Meta-analysis of clinical studies of the efficacy of granulocyte transfusions in the treatment of bacterial sepsis. J Clin Apher 1996;11:1-9.
17. Quillen K, Byrne P, Yau YY, Leitman SF. Ten-year followup of unrelated volunteer granulocyte donors who have received multiple cycles of granulocyte colony-stimulating factor and dexamethasone. Transfusion 2009;49:513-8.
18. Ofran Y, Avivi I, Oliven A, Oren I, Zuckerman T, Bonstein L, et al. Granulocyte transfusions for neutropenic patients with life-threatening infections: a single centre experience in 47 patients, who received 348 granulocyte transfusions. Vox Sang 2007;93:363-9.
19. Lee JJ, Song HC, Chung IJ, Bom HS, Cho D, Kim HJ. Clinical efficacy and prediction of response to granulocyte transfusion therapy for patients with neutropenia-related infections. Haematologica 2004;89:632-3.
20. Illerhaus G, Wirth K, Dwenger A, Waller CF, Garbe A, Brass V, et al. Treatment and prophylaxis of severe infections in neutropenic patients by granulocyte transfusions. Ann Hematol 2002;81:273-81.
21. Cesaro S, Chinello P, de Silvestro G, Marson P, Picco G, Varotto S, et al. Granulocyte transfusions from GCSF-stimulated donors for the treatment of severe infections in neutropenic pediatric patients with onco-hematological diseases. Support Care Cancer 2003;11:101-6.
22. Sachs UJH, Reiter A, Walter T, Bein G, Woessmann W. Safety and efficacy of therapeutic early onset granulocyte transfusions in pediatric patients with neutropenia and severe infections. Transfusion 2006;46:1909-14.
23. Seidel MG, Peters C, Wacker A, Northoff H, Moog R, Boehme A, et al. Randomized phase III study of granulocyte transfusions in neutropenic patients. Bone Marrow Transplant 2008;42:679-84.
24. Rutella S, Pierelli L, Piccirillo N, Sica S, Serafini R, Chiusolo P, et al. Efficacy of granulocyte transfusions for neutropenia-related infections: retrospective analysis of predictive factors. Cytotherapy 2003;5:19-30.
25. Dignani MC, Anaissie EJ, Hester JP, O'Brien S, Vartivarian SE, Rex JH, et al. Treatment of neutropenia-related fungal infections with granulocyte colony-stimulating factor-elicited white blood cell transfusions: a pilot study. Leukemia 1997;11:1621-30.
26. Roilides E, Uhlig K, Venzon D, Pizzo PA, Walsh TJ. Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon. Infect Immun 1993;61:4870-7.
27. Stroncek DF, Leonard K, Eiber G, Malech HL, Gallin JI, Leitman SF. Alloimmunization after granulocyte transfusions. Transfusion 1996;36:1009-15.
28. Nambiar A, Duquesnoy RJ, Adams S, Zhao Y, Oblitas J, Leitman S, et al. HLAMatchmaker-driven analysis of responses to HLA-typed platelet transfusions in alloimmunized thrombocytopenic patients. Blood 2006;107:1680-7.
29. Adkins DR, Goodnough LT, Shenoy S, Brown R, Moellering J, Khoury H, et al. Effect of leukocyte compatibility on neutrophil increment after transfusion of granulocyte colony-stimulating factor-mobilized prophylactic granulocyte transfusions and on clinical outcomes after stem cell transplantation. Blood 2000;95:3605-12.
30. Dignani MC, Rex JH, Chan KW, Dow G, deMagalhaes-Silverman M, Maddox A, et al. Immunomodulation with interferon-gamma and colony-stimulating factors for refractory fungal infections in patients with leukemia. Cancer 2005;104:199-204.